Related Experiment Video
Updated: Sep 21, 2025

Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation
Published on: January 19, 2024
Impaired Vagal Activity in Long-COVID-19 Patients
Domenico Acanfora1, Maria Nolano2,3, Chiara Acanfora1,4
1Department of Internal Medicine, San Francesco Hospital, Viale Europa 21, 82037 Telese Terme, Italy.
Insights
Long COVID-19 patients exhibit autonomic nervous system dysfunction, indicated by altered heart rate variability. This dysautonomia, linked to elevated D-dimer and NT-ProBNP, may explain persistent symptoms and requires monitoring.
Area of Science:
- Cardiology
- Neurology
- Infectious Diseases
Background:
- Long COVID-19, characterized by persistent symptoms post-acute infection, is associated with increased risks of multiorgan dysfunction, readmission, and mortality.
- Biomarkers such as D-Dimer and NT-ProBNP, along with autonomic nervous system dysfunction, are frequently observed in Long COVID-19 patients.
- The hypothesis of dysautonomia contributing to Long COVID-19 symptoms warrants further investigation.
Purpose of the Study:
- To investigate the presence and extent of dysautonomia in Long COVID-19 patients.
- To analyze heart rate variability (HRV) using 12-lead 24-h ECG monitoring in Long COVID-19 patients compared to a control group.
- To identify correlations between HRV parameters, specific biomarkers, and Long COVID-19 status.
Main Methods:
- Recruitment of 30 Long COVID-19 patients and 20 control subjects with no history of COVID-19.
- Utilized 12-lead 24-h electrocardiogram (ECG) monitoring for comprehensive heart rate variability assessment.
- Employed power spectral analysis to evaluate HRV components (Total Power, VLF, HF) and the LF/HF ratio.
Main Results:
- Long COVID-19 patients demonstrated significantly lower total power (p < 0.0001) and HF component (p = 0.015) of HRV.
- A significantly higher LF/HF ratio (p = 0.001) was observed in Long COVID-19 patients, indicating sympathetic-vagal imbalance.
- Multivariable analysis revealed significant correlations between Long COVID-19 and D-dimer (β=0.259), NT-ProBNP (β=0.281), HF component (β=0.696), and LF/HF ratio (β=0.820).
Conclusions:
- Dysautonomia, specifically impaired vagal activity, is a significant finding in Long COVID-19 patients.
- Persistent procoagulative state (elevated D-dimer) and myocardial strain (elevated NT-ProBNP) may contribute to vagal impairment.
- Careful monitoring and intervention are crucial for Long COVID-19 patients due to impaired vagal activity, elevated NT-ProBNP, and a prothrombotic state.
Abstract:
Long-COVID-19 refers to the signs and symptoms that continue or develop after the “acute COVID-19” phase. These patients have an increased risk of multiorgan dysfunction, readmission, and mortality. In Long-COVID-19 patients, it is possible to detect a persistent increase in D-Dimer, NT-ProBNP, and autonomic nervous system dysfunction. To verify the dysautonomia hypothesis in Long-COVID-19 patients, we studied heart rate variability using 12-lead 24-h ECG monitoring in 30 Long-COVID-19 patients and 20 No-COVID patients. Power spectral analysis of heart rate variability was lower in Long-COVID-19 patients both for total power (7.46 ± 0.5 vs. 8.08 ± 0.6; p < 0.0001; Cohens-d = 1.12) and for the VLF (6.84 ± 0.8 vs. 7.66 ± 0.6; p < 0.0001; Cohens-d = 1.16) and HF (4.65 ± 0.9 vs. 5.33 ± 0.9; p = 0.015; Cohens-d = 0.76) components. The LF/HF ratio was significantly higher in Long-COVID-19 patients (1.46 ± 0.27 vs. 1.23 ± 0.13; p = 0.001; Cohens-d = 1.09). On multivariable analysis, Long-COVID-19 is significantly correlated with D-dimer (standardized β-coefficient = 0.259), NT-ProBNP (standardized β-coefficient = 0.281), HF component of spectral analysis (standardized β-coefficient = 0.696), and LF/HF ratio (standardized β-coefficient = 0.820). Dysautonomia may explain the persistent symptoms in Long COVID-19 patients. The persistence of a procoagulative state and an elevated myocardial strain could explain vagal impairment in these patients. In Long-COVID-19 patients, impaired vagal activity, persistent increases of NT-ProBNP, and a prothrombotic state require careful monitoring and appropriate intervention.
More Related Videos
06:43Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cardiomyopathy VI: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation